Company: PTPI
Filing Date: 2025-02-13
Form Type: S-1/A
Source: 0001410578-25-000122
Chunk: 223

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-13
Form: S-1/A
Chunk 223
---
 annual periods beginning the year ended December 31, 2025. Early adoption is permitted. Upon adoption, the guidance can be applied prospectively or retrospectively. The Company is currently evaluating income tax disclosures related to its annual report for fiscal year 2025.

3) Accounts Receivable, net

Accounts receivable, net is comprised of the following:

| ​                               
 ​                               | ​ 
 ​ 
 ​ | ​    
 2023 |            ​ 
 December 31, | ​ 
 ​ | ​    
 2022 |            ​ 
 December 31, |
|:--------------------------------|:--|:-----|-------------:|:--|:-----|-------------:|
| Gross accounts receivables      | ​ | $    |    2,887,317 | ​ | $    |    2,757,839 |
| Distribution service fees       |   | ​    |     -398,968 |   | ​    |     -339,094 |
| Chargebacks accrual             |   | ​    |       -2,462 |   | ​    |       -1,960 |
| Cash discount allowances        |   | ​    |      -24,639 |   | ​    |      -99,671 |
| Allowance for doubtful accounts |   | ​    |     -235,097 |   | ​    |     -206,868 |
| Total accounts receivable, net  | ​ | $    |    2,226,151 | ​ | $    |    2,110,246 |

For the year ended December 31, 2023, gross billings to customers representing 10% or more of the Company’s total gross billings included customers which represented approximately %, %, and % of total gross billings. For the year ended December 31, 2022, gross billings to customers representing 10% or more of the Company’s total gross billings included customers which represented approximately %, %, %, and % of total gross billings.

F-16

Receivables from customers representing 10% or more of the Company’s gross accounts receivable included 3customers at December 31, 2023, equal to 36%, 24% and 16%, respectively, of the Company’s total gross accounts receivables. Receivables from customers representing 10% or more of the Company’s gross accounts receivable included twocustomers at December 31, 202